These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4352635)

  • 21. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 22. [The pathophysiology of some disorders of neuromuscular transmission].
    Elmqvist D
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):816-9. PubMed ID: 5089803
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular transmission in single motor units in myasthenia gravis.
    Mayer RF
    Muscle Nerve; 1982; 5(9S):S46-9. PubMed ID: 6302496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exchange in myasthenia gravis: electrophysiological studies.
    Campbell WW; Leshner RT; Swift TR
    Ann Neurol; 1980 Dec; 8(6):584-9. PubMed ID: 6260011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some different aspects of post-tetanic phenomena in myasthenia gravis.
    Pinelli P; Arrigo A; Mille T
    Electroencephalogr Clin Neurophysiol; 1967 Aug; 23(2):190. PubMed ID: 4166736
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse drug effects on neuromuscular transmission.
    Howard JF
    Semin Neurol; 1990 Mar; 10(1):89-102. PubMed ID: 2161128
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrodiagnostic studies in neuromuscular disease.
    Samaha FJ
    N Engl J Med; 1971 Nov; 285(22):1244-7. PubMed ID: 4329738
    [No Abstract]   [Full Text] [Related]  

  • 29. The kinetics of transmitter release in myasthenia gravis. II. An electrophysiological analysis of the replenishment of transmitter stores.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1973; 13(1):3-58. PubMed ID: 4353757
    [No Abstract]   [Full Text] [Related]  

  • 30. Incrementing responses in myasthenia gravis.
    Mayer RF; Williams IR
    Arch Neurol; 1974 Jul; 31(1):24-6. PubMed ID: 4365402
    [No Abstract]   [Full Text] [Related]  

  • 31. [The method of axonal stimulation (AS) for jitter evaluation in the diagnosis of neuromuscular transmission disorders].
    Michalska T; Rowińska K; Emeryk B
    Neurol Neurochir Pol; 1995; 29(3):333-42. PubMed ID: 7566408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accessory nerve stimulation in the assessment of myasthenia gravis.
    Schumm F; Stöhr M
    Muscle Nerve; 1984 Feb; 7(2):147-51. PubMed ID: 6717491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of prostigmin on the basal electromyogram in myasthenia.
    Wochnik-Dyjas D; Niewiadomska M
    Pol Med J; 1970; 9(4):932-8. PubMed ID: 4320112
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of electrophysiological response to thymectomy in patients with myasthenia gravis.
    Witoonpanich R
    J Med Assoc Thai; 2004 Nov; 87(11):1301-3. PubMed ID: 15825703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI
    Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kinetics of transmitter release in myasthenia gravis. 3. An electrophysiological analysis of the release of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1973; 13(2):145-73. PubMed ID: 4354573
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of anticholinesterases on motor unit potentials in myasthenia gravis.
    Pinelli P
    Muscle Nerve; 1978; 1(5):438-41. PubMed ID: 233739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recording of action potentials of a single muscle fiber and its clinical application--with special reference to single fiber electromyography].
    Konishi T
    Rinsho Byori; 1983 Oct; Spec No 57():105-18. PubMed ID: 6371318
    [No Abstract]   [Full Text] [Related]  

  • 39. Benefit from alternate-day prednisone in myasthenia gravis.
    Warmolts JR; Engel WK
    N Engl J Med; 1972 Jan; 286(1):17-20. PubMed ID: 4331158
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of prostigmin on the basal electromyogram in myasthenia.
    Wochnik-Dyjas D; Niewiadomska M
    Pol Med J; 1970; 9(3):730-7. PubMed ID: 4318132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.